CTNNB1 and hepatocellular carcinoma: Because CTNNB1 mutations were associated with higher CTNNB1 mRNA expression levels in HCC patients (Figure S1B), we used CTNNB1 gene expression levels to compare with paclitaxel drug activity in HCC cell lines.